Steve Borges, Leader of Regulated Industries Segment, Jabil : Hey, Ruplu, Steve here. Thanks for the question. To answer your question, first let me go back to my comments this time last year, and then I'll give you the go-forward perspective. I mentioned last year at this time, the overall med device market is growing roughly 3 to 4%. On that call, I said my expectation was we would return to growth in fiscal year 2026, driven by our past wins in the areas that Mike mentioned in his opening remarks, GLP and biologics growing and getting into production. That's continued as planned, most especially to answer your question on Croatia. Croatia is on track as planned. There have been no changes. There are no delays. That's moving forward as we anticipated. In addition, this year, your question about new wins. I'd say that we have quite a few new wins.